In cancer, degeneration of anti-tumor immune responses is caused by the activation, proliferation, and cytotoxic secretion of T cells in response to the activity of PD-1 and its ligand PD-L1 or PD-L2. The gene discussed is PDCD1; the disease is neoplasm.